Cargando…
P1498: INITIAL DATA FROM THE BEACON TRIAL: A PHASE 2, RANDOMIZED, OPEN-LABEL TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA
Autores principales: | Ross, Gayle, Stewart, Peter, Mensing, George, Chin, Melanie, Howell, Haley, Dahy, Andeleeb, Chan, Katherine, Daga, Pankaj, Mangus, Heidi, Savage, Will |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429836/ http://dx.doi.org/10.1097/01.HS9.0000972872.50738.0c |
Ejemplares similares
-
PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA
por: Levy, Cynthia, et al.
Publicado: (2023) -
Erythropoietic protoporphyria
por: Lecha, Mario, et al.
Publicado: (2009) -
Development and content validation of a sunlight exposure diary in patients with erythropoietic protoporphyria
por: Mathias, Susan D., et al.
Publicado: (2023) -
Microcytosis in Erythropoietic Protoporphyria
por: Graziadei, Giovanna, et al.
Publicado: (2022) -
Current trials in erythropoietic protoporphyria: are placebo controls ethical?
por: Barman-Aksözen, Jasmin, et al.
Publicado: (2023)